Sign In
Buy RKDA
$0.722
-0.0505 (-6.54%)
At Close: Jun 23, 2026
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10:00pm, Friday, 12'th Jun 2026
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced p
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08:00pm, Thursday, 11'th Jun 2026
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purc
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
04:05pm, Thursday, 14'th May 2026
-- Zola ® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia's history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and m
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
04:05pm, Thursday, 26'th Mar 2026
-- Zola ® revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination --
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
08:00am, Monday, 12'th Jan 2026
DALLAS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive ag
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
08:02am, Friday, 26'th Dec 2025
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a
Arcadia Biosciences (NASDAQ:RKDA) Shares Cross Below Fifty Day Moving Average – Here’s Why
04:14am, Friday, 05'th Dec 2025
Arcadia Biosciences, Inc. (NASDAQ: RKDA - Get Free Report) passed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $3.81 and traded as low as $3.59.
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
04:05pm, Friday, 07'th Nov 2025
-- Zola ® year-to-date revenues increase 26% year over year -- -- Arcadia gross profit margins exceed 30% for 11 th straight quarter -- -- Arcadia cash balance declines by only $257K to $1.1M -- DALL
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
04:30pm, Thursday, 14'th Aug 2025
-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola ® -- -- Arcadia receives 2.7 million shares of stock in ABVE --
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript
10:32am, Sunday, 11'th May 2025
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Execut
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
08:02am, Thursday, 08'th May 2025
-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater cer
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
08:02am, Tuesday, 29'th Apr 2025
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will release its financial and business results for the first quarter of 2025 on May 8, 2025 at 2:00 p.m. ET.
Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript
07:37pm, Thursday, 20'th Mar 2025
Arcadia Biosciences, Inc (NASDAQ:RKDA ) Q4 2024 Results Conference Call March 20, 2025 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executi
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights
04:05pm, Thursday, 20'th Mar 2025
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
08:02am, Thursday, 06'th Mar 2025
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial
